NASDAQ:IGMS

IGM Biosciences News Headlines

$62.27
+0.17 (+0.27 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$59.45
Now: $62.27
$64.60
50-Day Range
$62.10
MA: $82.43
$95.54
52-Week Range
$41.41
Now: $62.27
$133.00
Volume284,171 shs
Average Volume198,216 shs
Market Capitalization$1.91 billion
P/E RatioN/A
Dividend YieldN/A
Beta-1.12

Headlines

IGM Biosciences (NASDAQ IGMS) News Headlines Today

SourceHeadline
IGM Biosciences (NASDAQ:IGMS) Stock Rating Lowered by Zacks Investment ResearchIGM Biosciences (NASDAQ:IGMS) Stock Rating Lowered by Zacks Investment Research
marketbeat.com - April 3 at 12:15 AM
IGM Biosciences (NASDAQ:IGMS) Shares Gap Up to $62.10IGM Biosciences (NASDAQ:IGMS) Shares Gap Up to $62.10
americanbankingnews.com - April 13 at 11:52 AM
IGM Biosciences Appoints George Gauthier as Chief Commercial OfficerIGM Biosciences Appoints George Gauthier as Chief Commercial Officer
finance.yahoo.com - April 12 at 8:03 AM
IGM Biosciences (NASDAQ:IGMS) Trading Down 7.1%IGM Biosciences (NASDAQ:IGMS) Trading Down 7.1%
americanbankingnews.com - April 9 at 12:32 PM
Bruce Keyt Sells 1,254 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) StockBruce Keyt Sells 1,254 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) Stock
americanbankingnews.com - April 7 at 10:46 PM
IGM Biosciences (NASDAQ:IGMS) Shares Gap Down to $83.40IGM Biosciences (NASDAQ:IGMS) Shares Gap Down to $83.40
americanbankingnews.com - April 6 at 11:00 AM
IGM Biosciences, Inc. (NASDAQ:IGMS) Expected to Earn FY2025 Earnings of $0.28 Per ShareIGM Biosciences, Inc. (NASDAQ:IGMS) Expected to Earn FY2025 Earnings of $0.28 Per Share
americanbankingnews.com - April 1 at 9:00 AM
IGM Biosciences (NASDAQ:IGMS) Stock Price Up 6.2%IGM Biosciences (NASDAQ:IGMS) Stock Price Up 6.2%
americanbankingnews.com - March 31 at 1:04 PM
IGM Biosciences (NASDAQ:IGMS) Stock Rating Reaffirmed by HC WainwrightIGM Biosciences (NASDAQ:IGMS) Stock Rating Reaffirmed by HC Wainwright
americanbankingnews.com - March 31 at 8:36 AM
IGM Biosciences (NASDAQ:IGMS) Releases  Earnings Results, Misses Expectations By $0.05 EPSIGM Biosciences (NASDAQ:IGMS) Releases Earnings Results, Misses Expectations By $0.05 EPS
americanbankingnews.com - March 31 at 7:28 AM
IGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateIGM Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - March 30 at 6:40 PM
IGM Biosciences (IGMS) Scheduled to Post Earnings on TuesdayIGM Biosciences (IGMS) Scheduled to Post Earnings on Tuesday
americanbankingnews.com - March 25 at 10:52 AM
IGM Biosciences to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 30, 2021IGM Biosciences to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 30, 2021
finance.yahoo.com - March 24 at 8:37 AM
IGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Recommendation of "Buy" by AnalystsIGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Recommendation of "Buy" by Analysts
americanbankingnews.com - March 22 at 2:44 PM
IGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business OfficerIGM Biosciences Appoints Lisa Decker, Ph.D., as Chief Business Officer
finance.yahoo.com - March 15 at 8:29 AM
IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth PlansIGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - March 14 at 12:04 PM
Medivir to present at the H.C. Wainwright Global Life Sciences ConferenceMedivir to present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 9 at 1:37 PM
IGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology DayIGM Biosciences to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day
finance.yahoo.com - February 5 at 8:28 AM
Medivir sells global rights of birinapant to IGM BiosciencesMedivir sells global rights of birinapant to IGM Biosciences
seekingalpha.com - January 13 at 5:21 PM
IGM Biosciences to Present at the 39th Annual J.P. Morgan Healthcare ConferenceIGM Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 9:59 AM
This Biotech Skyrocketed 84% in 2 Days, But Is It Warranted?This Biotech Skyrocketed 84% in 2 Days, But Is It Warranted?
finance.yahoo.com - December 21 at 1:49 PM
Is IGMS A Good Stock To Buy Now?Is IGMS A Good Stock To Buy Now?
finance.yahoo.com - December 17 at 4:37 PM
Wednesday 12/16 Insider Buying Report: IGMS, ALXOWednesday 12/16 Insider Buying Report: IGMS, ALXO
nasdaq.com - December 16 at 12:40 PM
Have Insiders Been Buying IGM Biosciences, Inc. (NASDAQ:IGMS) Shares?Have Insiders Been Buying IGM Biosciences, Inc. (NASDAQ:IGMS) Shares?
finance.yahoo.com - December 14 at 10:03 AM
IGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters Option to Purchase Additional SharesIGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
marketwatch.com - December 11 at 6:43 PM
IGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesIGM Announces Closing of $230 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 11 at 6:43 PM
Pelareorep Along With Checkpoint Inhibitors Proving Critically Important for Early Stage Breast CancerPelareorep Along With Checkpoint Inhibitors Proving Critically Important for Early Stage Breast Cancer
marketwatch.com - December 9 at 11:55 AM
IGM Announces Pricing of Upsized $200 million Public OfferingIGM Announces Pricing of Upsized $200 million Public Offering
finance.yahoo.com - December 8 at 10:42 PM
Why Is It Moving? Looking Into Why IGM Biosciencess Stock is Trading Higher TodayWhy Is It Moving? Looking Into Why IGM Biosciences's Stock is Trading Higher Today
benzinga.com - December 8 at 3:50 PM
IGM Announces Proposed Public OfferingIGM Announces Proposed Public Offering
finance.yahoo.com - December 7 at 7:48 PM
IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkins Lymphoma at 2020 ASH Annual MeetingIGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkin's Lymphoma at 2020 ASH Annual Meeting
benzinga.com - December 5 at 4:27 PM
IGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkin’s Lymphoma at 2020 ASH Annual MeetingIGM Biosciences Presents First Clinical Data from IGM-2323 in Non-Hodgkin’s Lymphoma at 2020 ASH Annual Meeting
finance.yahoo.com - December 5 at 4:26 PM
Notable Wednesday Option Activity: LMND, IGMS, ISRGNotable Wednesday Option Activity: LMND, IGMS, ISRG
nasdaq.com - December 2 at 4:29 PM
IGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 62nd Annual ASH MeetingIGM Biosciences to Host Conference Call and Webcast to Review IGM-2323 Data Presented at the 62nd Annual ASH Meeting
finance.yahoo.com - November 30 at 8:13 AM
IGM Biosciences to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceIGM Biosciences to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 23 at 7:38 AM
IGM Biosciences Announces Third Quarter 2020 Financial Results and Provides Corporate UpdateIGM Biosciences Announces Third Quarter 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - November 5 at 8:12 AM
IGM Biosciences, Inc. Common Stock (IGMS)IGM Biosciences, Inc. Common Stock (IGMS)
nasdaq.com - November 2 at 6:58 PM
Investigating IGM BiosciencesInvestigating IGM Biosciences
seekingalpha.com - October 13 at 5:56 AM
IGM Biosciences, Inc. (1K0.F)IGM Biosciences, Inc. (1K0.F)
in.finance.yahoo.com - October 10 at 7:55 AM
IGM Biosciences starts early-stage study for IgM antibody in solid cancers and NHLIGM Biosciences starts early-stage study for IgM antibody in solid cancers and NHL
seekingalpha.com - September 30 at 12:33 PM
IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-8444 for the Treatment of Solid Cancers and Non-Hodgkin’s LymphomaIGM Biosciences Initiates First-in-Human Clinical Trial of IGM-8444 for the Treatment of Solid Cancers and Non-Hodgkin’s Lymphoma
markets.businessinsider.com - September 30 at 7:33 AM
Calithera Lung Cancer Trial, And Other News: The Good, Bad And Ugly Of BiopharmaCalithera Lung Cancer Trial, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - September 28 at 2:59 PM
AbCellera and IGM Biosciences collaborates to develop antibodiesAbCellera and IGM Biosciences collaborates to develop antibodies
seekingalpha.com - September 24 at 5:25 PM
AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery CollaborationAbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration
feeds.benzinga.com - September 24 at 4:17 PM
AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery CollaborationAbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration
feeds.benzinga.com - September 24 at 4:17 PM
Scientific Games and Cracker Barrel See Activist ActionScientific Games and Cracker Barrel See Activist Action
finance.yahoo.com - September 18 at 7:50 PM
IGM Biosciences +15%, named as possible takeover targetIGM Biosciences +15%, named as possible takeover target
seekingalpha.com - September 18 at 12:52 PM
IGM Biosciences (IGMS) Catches Eye: Stock Jumps 8.7%IGM Biosciences (IGMS) Catches Eye: Stock Jumps 8.7%
finance.yahoo.com - September 16 at 10:05 AM
Heres Why Were Not Too Worried About IGM Biosciences (NASDAQ:IGMS) Cash Burn SituationHere's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation
finance.yahoo.com - September 14 at 8:24 PM
Here's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn SituationHere's Why We're Not Too Worried About IGM Biosciences' (NASDAQ:IGMS) Cash Burn Situation
finance.yahoo.com - September 14 at 2:01 PM
IGM Biosciences to Present at Four Upcoming Investor ConferencesIGM Biosciences to Present at Four Upcoming Investor Conferences
finance.yahoo.com - September 2 at 7:33 AM
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.